Joel T. Arcari

Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections

Justin I. Montgomery, Matthew F. Brown, Usa Reilly et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

Pharmaceutical Science, Pharmacotherapy, New Series +19

Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections

Matthew F. Brown, Usa Reilly, J. A. Abramite et al. · Journal of Medicinal Chemistry · 2011 · 97 citations · Full text

PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy

Jitesh P. Jani, Joel T. Arcari, Vincent Bernardo et al. · Molecular Cancer Therapeutics · 2010 · 87 citations

Cancer Therapy, Tumor Biology, Drug Targeting +15

Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity

Matthew F. Brown, Mark J. Mitton‐Fry, Joel T. Arcari et al. · Journal of Medicinal Chemistry · 2013 · 63 citations

Antibiotics, Compound 17, Medicine +11

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner et al. · Journal of Medicinal Chemistry · 2024 · 59 citations · Full text